Antin to acquire Emsere from Gryphion.

Antin, a private equity firm, agreed to acquire Emsere, a clinical trial solutions partner specializing in the provision of medical devices and laboratory equipment, from Gryphion, a family investment platform. Financial terms are not disclosed. “We are delighted to be partnering with Emsere’s management to support the company in its next stage of growth. Emsere is a global leader in an important and fast-growing segment of the social infrastructure sector, underpinned by favourable tailwinds and high barriers to entry. We are looking forward to working with Patrice and his team to seize the many opportunities ahead to consolidate Emsere’s position as the integrated equipment partner of choice for pharma companies and contract research organisations globally,” Angelika Schöchlin, Antin Infrastructure Partners Managing Partner.